MEDIUM CARDIOVASCULAR SCREENING
The medium cardiovascular screening provides a thorough heart check-up. In addition to the test provided in the basic screening you can expect:
- Transthoracic Echocardiogram.
- 24h Ambulatory (Holter) ECG
- Laboratory testing for cardiovascular risk assessment.
- Cardiovascular overall risk assessment
A Transthoracic Echocardiogram
is an imaging test that creates images of your heart as it beats. It is considered to be one of the most accurate, screening tests to obtain information about heart disease prevention. The images will show the size of the heart chambers, how well the heart pumps and if there’s any valve abnormalities.
The 24h Ambulatory (Holter)
electrocardiogram is a widely used, noninvasive, test. It is one of the best clinical tools to assess the risk associated with cardiac rhythm abnormalities in patients with unexplained recurrent palpitations or episodic dizziness, as well as in healthy asymptomatic persons. The characteristic function of this test, in contrast to the standard resting ECG, is to continuously examine the patient’s cardiac rhythm over 24 hours, during normal activities, including any physical or psychological changes.
Some Laboratory test
may offer important clues about the heart health. Our panel include a lipid profile (total cholesterol, HDL and tryglicerides), fasting blood sugar and C-reactive protein, a sensitive marker of systemic inflammation and a powerful predictor of cardiovascular disease.
This test requires a sample of blood that will be collected by inserting a needle into a vein in your arm, usually at the bend in your elbow. The blood sample is then sent to the lab for analysis. It is required at least 12 hours fasting prior to test. You may drink plain water on the morning of your appointment. This test has no downsides. You may feel a slight pricking sensation, but it should not be painful.
the laboratory results allows the doctor to calculate a score as a % chance of developing a cardiovascular disease in the next 10 years, offering guidance on the appropriate management of specific risk factors or initiation of therapy for primary prevention (e.g. aspirin).